Skip to content
Abierto
Menu

Award notice

Center for Biologics Evaluation and Research (CBER), Biologics Effectiveness and Safety (BEST) Initiative #3: Data Sources for Surveillance of Biologics

75F40124R00002-Acumen

Food and Drug Administration, FDA Office of Acq Grant SVCS. Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services.

View on SAM.govMarkdown

Awarded

Acumen LLC

$75,000,000.00 on the award notice, September 27, 2024, contract 75F40124D00041

Description

As published on SAM.gov.

Multiple Award Indefinite Delivery / Indefinite Quantity (ID/IQ) contract for the Food and Drug Administration (FDA), Center for Biologics Evaluation and Research (CBER), Biologics Effectiveness and Safety (BEST)

Initiative #3: Health Care Data Sources for Surveillance of Biologics (BEST 3). $75,000,000.00 IDIQ ceiling for each contract.

The contract, on USAspending

Federal procurement data the awarding office reported to FPDS, matched to this solicitation by its number.

Recipient
Acumen LLC
UEI
XVMTJF1497P1
CAGE
3MQD9
Vendor location
Burlingame, CA
Contract
75F40124D00041
Obligated
$10,000.00, potential $75,000,000
Actions
2 between September 27, 2024 and July 22, 2025
Competition
Full and Open Competition, 8 offers received
Set-aside reported
No Set Aside Used.
Described as
Center for Biologics Evaluation and Research (Cber) Has a Requirement for Their Biologics Effectiveness and Safety (Best) Initiative #3: Health Care Data Sources for Surveillance of Biologics (Best 3)
Match
award number 75F40124D00041 equals the contract number; same awarding office 75F401 (high confidence)
Record
USAspending award page

Publications

Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.

  1. September 27, 2024

    Award notice, originally solicitation

    Awarded to ACUMEN LLC Burlingame for $75,000,000. SAM.gov, notice 0903a46e9ab34585b0c4db0b7f4d0952

Points of contact

Also open from this buyer